Methylxanthines [recurso electrónico] / by Bertil B. Fredholm.

Por: Fredholm, Bertil B [author.]Colaborador(es): SpringerLink (Online service)Tipo de material: TextoTextoSeries Handbook of Experimental Pharmacology ; 200Editor: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011Descripción: XV, 559p. 6 illus., 4 illus. in color. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783642134432Tema(s): Medicine | Neurochemistry | Toxicology | Biochemistry | Biomedicine | Pharmacology/Toxicology | Neurochemistry | Medical BiochemistryFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 615 Clasificación LoC:RM1-950Recursos en línea: Libro electrónicoTexto En: Springer eBooksResumen: In the present volume of the Handbook of Experimental Pharmacology well known experts describe the actions of different xanthines with a focus on caffeine and theophylline. A special chapter is devoted to theobromine, an active component of chocolate, the actions of which are less well characterized. This book also presents the pharmacology of one xanthine derivative, propentofylline, as an example of a xanthine that has gone through extensive development for a novel therapeutic area.
Star ratings
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura Copia número Estado Fecha de vencimiento Código de barras
Libro Electrónico Biblioteca Electrónica
Colección de Libros Electrónicos RM1 -950 (Browse shelf(Abre debajo)) 1 No para préstamo 374492-2001

In the present volume of the Handbook of Experimental Pharmacology well known experts describe the actions of different xanthines with a focus on caffeine and theophylline. A special chapter is devoted to theobromine, an active component of chocolate, the actions of which are less well characterized. This book also presents the pharmacology of one xanthine derivative, propentofylline, as an example of a xanthine that has gone through extensive development for a novel therapeutic area.

19

Con tecnología Koha